Crossref
The role of vorasidenib, a dual inhibitor of the mutant IDH1 and IDH2 enzymes, in the treatment of diffuse adult-type gliomas
Oncology in Clinical Practice · 15.01.2026 · 22
DOI: 10.5603/ocp.110138 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology in Clinical Practice, online erschienen am 15.01.2026. Verfasst von Tomasz Kubiatowski und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kubiatowski, T., & Iżycka-Świeszewska, E. (2026). The role of vorasidenib, a dual inhibitor of the mutant IDH1 and IDH2 enzymes, in the treatment of diffuse adult-type gliomas. Oncology in Clinical Practice, 22(0). https://doi.org/10.5603/ocp.110138
Vancouver
Kubiatowski T, Iżycka-Świeszewska E. The role of vorasidenib, a dual inhibitor of the mutant IDH1 and IDH2 enzymes, in the treatment of diffuse adult-type gliomas. Oncology in Clinical Practice. 2026;22(0). doi:10.5603/ocp.110138
BibTeX
@article{Kubiatowski2026,
author = {Kubiatowski, Tomasz and Iżycka-Świeszewska, Ewa},
title = {The role of vorasidenib, a dual inhibitor of the mutant IDH1 and IDH2 enzymes, in the treatment of diffuse adult-type gliomas},
journal = {Oncology in Clinical Practice},
year = {2026},
volume = {22},
number = {0},
doi = {10.5603/ocp.110138}
}
EUVIMED